1. Phase II evaluation of the AMAP, 773U82 mesylate, in pancreatic cancer

   • Donald L. Trump
   • James A. Hathorn
   • John A. Hohneker

   OriginalPaper Pages: 273 - 276

2. Phase I study of mitonafide with a 3-day administration schedule: Early interruption due to severe central nervous system toxicity

   • Eduardo Díaz-Rubio
   • Miguel Martín
   • Ana Benavides

   OriginalPaper Pages: 277 - 281

3. Phase I/II trial of dipyridamole, 5-fluorouracil, leukovorin, and mitoxantrone in metastatic breast cancer

   • G. Thomas Budd
   • Pamela Herzog
   • Ronald M. Bukowski

   OriginalPaper Pages: 283 - 287

4. Postincubation with aclarubicin reverses topoisomerase II mediated DNA cleavage, strand breaks, and cytotoxicity induced by VP-16

   • Lone Nørgård Petersen
   • Peter Buhl Jensen
   • Mogens Spang-Thomsen

   OriginalPaper Pages: 289 - 297

5. High-dose aminothiadiazole in advanced colorectal cancer

   • Gershon Y. Locker
   • Lary Kilton
   • Al. B. Benson III

   OriginalPaper Pages: 299 - 301

6. Pharmaceutical development of a parenteral formulation of the novel anti-tumor agent carzelesin (U-80,244)

   • Jantine D. Jonkman de Vries
   • Marga J. A. de Graaff-Teulen
   • Jos H. Beijnen

   OriginalPaper Pages: 303 - 314

7. Phase II study of elsamitrucin in non-small cell lung cancer

   • Glenwood Goss
   • François Letendre
   • Elizabeth Eisenhauer

   Brief Report Pages: 315 - 317

8. Phase II trial of PALA and 6-methylmercaptopurine riboside (MMPR) in combination with 5-fluorouracil in advanced pancreatic cancer

   • Istvan Redei
   • Fran Green
   • Peter J. O'Dwyer

   OriginalPaper Pages: 319 - 321

9. Phase II trial of liposomal encapsulated doxorubicin in patients with advanced renal cell carcinoma

   • Teresa Murray Law
   • Peter Mencel
   • Robert J. Motzer

   Brief Report Pages: 323 - 325

10. Phase II study of carboplatin and edatrexate (10-EdAM) with leucovorin rescue for patients with recurrent squamous cell carcinoma of the head and neck

    • Martin H. Huber
    • Isaiah W. Dimery
    • Waun Ki Hong

    OriginalPaper Pages: 327 - 331

11. Phase II trial of piroxantrone in metastatic breast cancer

    • Peter M. Ravdin
    • Stephanie Green
    • Silvana Martino

    OriginalPaper Pages: 333 - 336

12. Hepatoma/merbarone

    • Elizabeth A. Poplin
    • Catherine M. Tangen
    • John S. Macdonald

    OriginalPaper Pages: 337 - 340

13. Phase II study of edatrexate in advanced head and neck cancer

    • J. Philip Kuebler
    • Jacqueline Benedetti
    • Manly E. Marshall

    OriginalPaper Pages: 341 - 344

14. Phase II trial of 6-thioguanine in advanced renal cell carcinoma

    • Daniel H. Shevrin
    • Lary J. Kilton
    • Al. B. Benson III

    OriginalPaper Pages: 345 - 346